Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 38,241	$ 62,789
Restricted cash	256,237	0
Derivative asset	17,958	0
Prepaid expenses and other current assets	2,089	1,149
Total current assets	314,525	63,938
Property, plant and equipment, net	2,437,733	218,646
Operating lease right-of-use assets	170,827	1,474
Debt issuance costs	389,695	0
Other non-current assets	11,021	28,372
Total assets	3,323,801	312,430
Current liabilities:
Accounts payable	243,129	1,084
Accrued and other current liabilities	299,264	23,184
Common stock warrant liabilities	6,851	0
Operating lease liabilities	3,143	1,093
Total current liabilities	552,387	25,361
Common stock warrant liabilities	1,818	6,790
Operating lease liabilities	145,962	465
Derivative liability	66,899	0
Debt, net	1,816,301	0
Other non-current liabilities	0	23,000
Total liabilities	2,583,367	55,616
Commitments and contingencies (Note 16)
Series A-C convertible preferred stock (Note 10)	0	202,443
Stockholders’ equity:
Common stock, $0.0001 par value, 480.0 million authorized: 256.5 million and 143.5 million outstanding, respectively	26	14
Treasury stock: 2.2 million and 1.0 million respectively, at cost	(14,214)	(4,587)
Preferred stock, $0.0001 par value, 0.5 million authorized after designation of the convertible preferred stock: none outstanding	0	0
Additional paid-in-capital	693,883	289,084
Accumulated deficit	(391,772)	(230,140)
Total stockholders' equity	287,923	54,371
Non-controlling interest	452,511	0
Total equity	740,434	54,371
Total liabilities, convertible preferred stock and stockholders’ equity	$ 3,323,801	$ 312,430